Prognostic and predictive role of RBsig and CCNE1/RB1 gene-expression signatures for patients with early breast cancer treated with endocrine therapy with or without palbociclib in the PALLAS trial (ABCSG-42, AFT-05, BIG 14-03)
Google Scholar   
Citation:
Meeting Instance:
SABCS 2025
Year:
2025
Type:
Abstract
Sub type:
Poster General
Funding:
AFT
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
AFT, ABCSG, ECOG-ACRIN, NSABP Foundation, GBG, BIG  
Corr. Author:
 
Authors:
                                                 
Networks:
LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-PA015, LAPS-TX035   
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: